Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance
Standard
Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. / Suez, Jotham; Cohen, Yotam; Valdés-Mas, Rafael; Mor, Uria; Dori-Bachash, Mally; Federici, Sara; Zmora, Niv; Leshem, Avner; Heinemann, Melina; Linevsky, Raquel; Zur, Maya; Ben-Zeev Brik, Rotem; Bukimer, Aurelie; Eliyahu-Miller, Shimrit; Metz, Alona; Fischbein, Ruthy; Sharov, Olga; Malitsky, Sergey; Itkin, Maxim; Stettner, Noa; Harmelin, Alon; Shapiro, Hagit; Stein-Thoeringer, Christoph K; Segal, Eran; Elinav, Eran.
In: CELL, Vol. 185, No. 18, 01.09.2022, p. 3307-3328.e19.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance
AU - Suez, Jotham
AU - Cohen, Yotam
AU - Valdés-Mas, Rafael
AU - Mor, Uria
AU - Dori-Bachash, Mally
AU - Federici, Sara
AU - Zmora, Niv
AU - Leshem, Avner
AU - Heinemann, Melina
AU - Linevsky, Raquel
AU - Zur, Maya
AU - Ben-Zeev Brik, Rotem
AU - Bukimer, Aurelie
AU - Eliyahu-Miller, Shimrit
AU - Metz, Alona
AU - Fischbein, Ruthy
AU - Sharov, Olga
AU - Malitsky, Sergey
AU - Itkin, Maxim
AU - Stettner, Noa
AU - Harmelin, Alon
AU - Shapiro, Hagit
AU - Stein-Thoeringer, Christoph K
AU - Segal, Eran
AU - Elinav, Eran
N1 - Copyright © 2022 Elsevier Inc. All rights reserved.
PY - 2022/9/1
Y1 - 2022/9/1
N2 - Non-nutritive sweeteners (NNS) are commonly integrated into human diet and presumed to be inert; however, animal studies suggest that they may impact the microbiome and downstream glycemic responses. We causally assessed NNS impacts in humans and their microbiomes in a randomized-controlled trial encompassing 120 healthy adults, administered saccharin, sucralose, aspartame, and stevia sachets for 2 weeks in doses lower than the acceptable daily intake, compared with controls receiving sachet-contained vehicle glucose or no supplement. As groups, each administered NNS distinctly altered stool and oral microbiome and plasma metabolome, whereas saccharin and sucralose significantly impaired glycemic responses. Importantly, gnotobiotic mice conventionalized with microbiomes from multiple top and bottom responders of each of the four NNS-supplemented groups featured glycemic responses largely reflecting those noted in respective human donors, which were preempted by distinct microbial signals, as exemplified by sucralose. Collectively, human NNS consumption may induce person-specific, microbiome-dependent glycemic alterations, necessitating future assessment of clinical implications.
AB - Non-nutritive sweeteners (NNS) are commonly integrated into human diet and presumed to be inert; however, animal studies suggest that they may impact the microbiome and downstream glycemic responses. We causally assessed NNS impacts in humans and their microbiomes in a randomized-controlled trial encompassing 120 healthy adults, administered saccharin, sucralose, aspartame, and stevia sachets for 2 weeks in doses lower than the acceptable daily intake, compared with controls receiving sachet-contained vehicle glucose or no supplement. As groups, each administered NNS distinctly altered stool and oral microbiome and plasma metabolome, whereas saccharin and sucralose significantly impaired glycemic responses. Importantly, gnotobiotic mice conventionalized with microbiomes from multiple top and bottom responders of each of the four NNS-supplemented groups featured glycemic responses largely reflecting those noted in respective human donors, which were preempted by distinct microbial signals, as exemplified by sucralose. Collectively, human NNS consumption may induce person-specific, microbiome-dependent glycemic alterations, necessitating future assessment of clinical implications.
KW - Adult
KW - Animals
KW - Aspartame/pharmacology
KW - Blood Glucose
KW - Humans
KW - Mice
KW - Microbiota
KW - Non-Nutritive Sweeteners/analysis
KW - Saccharin/pharmacology
U2 - 10.1016/j.cell.2022.07.016
DO - 10.1016/j.cell.2022.07.016
M3 - SCORING: Journal article
C2 - 35987213
VL - 185
SP - 3307-3328.e19
JO - CELL
JF - CELL
SN - 0092-8674
IS - 18
ER -